Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
3.220
+0.060 (1.90%)
At close: Jun 27, 2025, 4:00 PM
3.100
-0.120 (-3.73%)
After-hours: Jun 27, 2025, 7:42 PM EDT
Sintx Technologies Employees
Sintx Technologies had 20 employees as of December 31, 2024. The number of employees decreased by 23 or -53.49% compared to the previous year.
Employees
20
Change (1Y)
-23
Growth (1Y)
-53.49%
Revenue / Employee
$128,450
Profits / Employee
-$621,500
Market Cap
8.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SINT News
- 4 days ago - SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market - GlobeNewsWire
- 5 weeks ago - SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market - GlobeNewsWire
- 6 weeks ago - SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization - GlobeNewsWire
- 4 months ago - SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 4 months ago - SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market - GlobeNewsWire
- 4 months ago - SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial - GlobeNewsWire
- 7 months ago - SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - GlobeNewsWire
- 7 months ago - SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer - GlobeNewsWire